Early triple antiviral therapy for COVID-19

Similar Items

• Accelerating antiviral drug discovery: lessons from COVID-19
  by: von Delft, A, et al.
  Published: (2023)
• Repurposed antiviral drugs for Covid-19 - Interim WHO Solidarity trial results
  by: Pan, H, et al.
  Published: (2020)
• Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
  by: Luvira, V, et al.
  Published: (2024)
• Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
  by: Gbinigie, O, et al.
  Published: (2023)
• Delayed mucosal antiviral responses despite robust peripheral inflammation in fatal COVID-19
  by: Sidhu, JK, et al.
  Published: (2023)